Simplex Quantum Presents AI-Powered Heart Failure Detection at THT 2024 Shark Tank Innovation Competition

(BOSTON, USA) Simplex Quantum successfully participated in the 2024 THT Shark Tank Innovation Competition as part of the Technology and Heart Failure Therapeutics (THT) 2024 conference in Boston, organized by the Cardiovascular Research Foundation (CRF). The event, which brings together leading experts in cardiology, regulatory affairs, and venture capital, showcased cutting-edge innovations in heart failure management.
THT Website: https://tht.crfconferences.com/

On March 5, we presented NIHA-HF, our AI-powered heart failure detection technology, at THT 2024’s Shark Tank session. This pioneering solution leverages single-lead ECG data and artificial intelligence to provide real-time heart failure risk assessments, offered a non-invasive and scalable approach to early detection and monitoring.

Why NIHA-HF Matters

Heart failure remains a global health crisis, affecting millions worldwide and placing a significant burden on healthcare systems. NIHA-HF is designed to revolutionize heart failure diagnostics by:

• Providing early detection through AI-based analysis of single-lead ECG data.
• Enabling remote monitoring, empowering both patients and clinicians with actionable insights.
• Integrating seamlessly with wearable technology, making advanced diagnostics more accessible.

Simplex Quantum continues to drive innovation in cardiovascular AI solutions, aiming to expand NIHA-HF’s clinical applications and improve heart failure diagnostics worldwide. Participating in THT 2024 marks an important milestone in our journey to bring NIHA-HF to broader clinical use, reinforcing our mission to improve heart failure detection and management globally.

Note: NIHA-HF is an investigational device and has not yet been approved by the FDA.